Respiratory Diseases Roundup
Respiratory Diseases Roundup
08/16/2024
Anthony Calabro, MA
In this respiratory disease roundup, researchers report on the efficacy of nirmatrelvir-ritonavir for treating Long COVID, the CDC updates recommendations on “triple threat” vaccines for respiratory virus...
08/16/2024
Research Summary
Research Summary
03/26/2024

Jessica Ganga

Jessica Ganga
The Advisory Committee on Immunization Practices released its updated annual immunization schedule for 2024 that includes new sections on respiratory syncytial virus (RSV), and the mpox (monkeypox) and...
03/26/2024
Research Summary
Research Summary
03/05/2024

Anthony Calabro, MA

Anthony Calabro, MA
The CDC updated its guidance due to the United States seeing fewer hospitalizations associated with COVID-19 and because there are numerous tools to combat influenza, COVID-19, and respiratory syncytial...
03/05/2024
COVID-19 Roundup
COVID-19 Roundup
01/17/2024

Jessica Ganga

Jessica Ganga
This COVID-19 roundup includes coverage of the FDA’s guidance for the correct Moderna vaccine dosage for pediatric patients, COVID-19 outcomes for patients with hypertension and diabetes, and the risk of...
01/17/2024
FDA Alert
FDA Alert
08/24/2023

Anthony Calabro, MA

Anthony Calabro, MA
Earlier this year, the FDA approved the same vaccine for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.
08/24/2023
FDA Alert
FDA Alert
07/24/2023

Jessica Ganga

Jessica Ganga
Following three clinical trials, the FDA has approved a new preventive treatment for neonates, infants, and toddlers that prevents respiratory syncytial virus (RSV) in those age populations.
07/24/2023
FDA alert
FDA alert
05/04/2023

Jessica Ganga

Jessica Ganga
After an ongoing study, the FDA approves the first vaccine for the highly contagious respiratory virus for us in the United States.
05/04/2023